Company Report
Last edited a month ago
PerformanceCommunity EngagementCommunity Endorsement
ranked
#8
Performance (39m)
27.9% pa
Followed by
19
Straws
Sort by:
Recent
Content is delayed by one month. Upgrade your membership to unlock all content. Click for membership options.
#Risks
Last edited a month ago

Interesting watching the chatter vaporise around Clarity.

The speccy biotech's share price has plummeted from almost $9 to $2.13 in months as the hype has settled.

Shouldn't the high conviction types be going in hard ?

Where's all the love gone ?

"It's a deal! It's a steal, It's the sale of the century! It's chicken soup!" (quote from Lock, Stock, &..)

Anyways, I'm genuinely sorry fo the peeps that succumbed to the bbq/lunch hype and bought at the peak.

A few years ago that was me, and it was one of the best investing lessons I've ever had.

I'm extemely grateful it happened at the beginning of my investing journey and not now.

Obviously it's a long road, and the company may still commercialise and start selling its miracle cure.

I hope so, but until it de-risks and starts selling the stuff, it's still on the watch list for me.

Alternatively, we could see cap raises and this drawn out likely over years.

Would have made more of a return probably just buying a broad based etf at the beginning of the story.